Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.77%
SPX
+0.83%
IXIC
+1.02%
FTSE
0.00%
N225
+0.06%
AXJO
+0.08%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
5.14B
Dividend Yield
0.00%
P/E Ratio
-18.48
EPS
-5.99
Revenue
385.69M
Avg. Volume
606.49K

Recently from Cashu

publisher logo
Cashu

Diverging Analyst Views Shape Future Outlook for Axsome Therapeutics Stock

2 days ago
publisher logo
Cashu

Regulatory Setback for Axsome Therapeutics: FDA Refusal Impacts AXS-14 Development

24 days ago
publisher logo
Cashu

Axsome Therapeutics Faces FDA Refusal for AXS-14 Fibromyalgia Treatment Submission

26 days ago

About

What does AXSM do?
Axsome Therapeutics, based in New York City, develops therapies for central nervous system disorders, with commercial products Auvelity and Sunosi, and investigational drugs AXS-05 and AXS-07. The company employs 545 staff and went public in November 2015.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
New York, USA
Website
http://www.axsome.com
Stocks
Health Care
axsm
Axsome Therapeutics
AXSM
+1.53 (+1.47%)
105.44
USD
At close at Jul 04, 20:41 UTC
Summary
News
Signals
Benchmarks
Financials